Covance
120
2
3
89
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
20.0%
24 terminated/withdrawn out of 120 trials
78.8%
-7.8% vs industry average
16%
19 trials in Phase 3/4
44%
39 of 89 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (120)
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Role: collaborator
A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.
Role: collaborator
A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
Role: collaborator
Staccato Loxapine Thorough QT/QTc Study
Role: collaborator
Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.
Role: collaborator
Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects
Role: collaborator
Mass Balance Study of KBP-5074 in Healthy Male Subjects
Role: collaborator
Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment
Role: collaborator
First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma
Role: collaborator
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer
Role: collaborator
ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies
Role: collaborator
A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
Role: collaborator
Study of the Gut Hormone Analogue Y14 in Adult Subjects
Role: collaborator
A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Role: collaborator
Study to Evaluate Changes in Smokers Using on!® Nicotine Pouches
Role: collaborator
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
Role: collaborator
Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients
Role: collaborator
Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects
Role: collaborator
Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers
Role: collaborator
A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)
Role: collaborator